Compounds > clarithromycin
Page last updated: 2024-08-25

clarithromycin and linezolid

clarithromycin has been researched along with linezolid in 62 studies

Research

Studies (62)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's20 (32.26)29.6817
2010's32 (51.61)24.3611
2020's10 (16.13)2.80

Authors

AuthorsStudies
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S1
Cirioni, O; Della Vittoria, A; Giacometti, A; Kamysz, W; Nadolski, P; Riva, A; Scalise, G; Silvestri, C; Łukasiak, J1
Chang, CL; Jeong, J; Jeong, SH; Jung, HJ; Kim, HR; Kim, S; Lee, EY; Lee, JN; Shin, JH1
Andricopulo, AD; Moda, TL; Montanari, CA1
Baudry, PJ; DeCorby, M; Hoban, DJ; Johnson, J; Karlowsky, JA; Lagacé-Wiens, P; Laing, N; McCracken, M; Mulvey, MR; Nichol, KA; Tailor, F; Vashisht, R; Walkty, A; Weshnoweski, B; Wierzbowski, A; Zhanel, GG1
Lombardo, F; Obach, RS; Waters, NJ1
Bohnert, JA; Fähnrich, E; Kern, WV; Schuster, S; Wehmeier, C1
Cui, L; Hiramatsu, K; Neoh, HM; Shoji, M1
Gikas, A; Psaroulaki, A; Spyridaki, I; Tselentis, Y; Vranakis, I1
Chen, H; Chen, M; Liu, Y; Ma, Y; Nichols, WW; Sun, W; Wang, H; Zhang, J; Zhao, C1
Gaillard, JL; Jackson, M; McDonnell, G; Niederweis, M; Skovierová, H; Svetlíková, Z1
Amaral, K; Dzink-Fox, J; Fischer, E; Goldovitz, J; Manni, K; Neckermann, G; Osborne, CS; Pecanka, R; Ryder, NS; Yu, D1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Bishai, WR; Grosset, JH; Nuermberger, EL; Zhang, T1
Bohnert, JA; Karamian, B; Nikaido, H1
Chen, JM; Granskog, K; Han, S; Huband, MD; Magee, TV; Maguire, BA; Marr, ES; McCurdy, SP; Nguyen, TT; Shanmugasundaram, V; Subashi, TA1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bi, F; Cai, X; Gu, X; Hu, C; Liu, Z; Ma, S; Song, D; Venter, H; Zhang, N1
Bi, F; Liu, X; Ma, S; Qin, Y; Song, D; Teng, Y; Zhang, N1
Apfalter, P; Hirschl, AM; Makristathis, A; Rotter, ML; Wimmer, M1
Gikas, A; Psaroulaki, A; Scoulica, E; Spyridaki, I; Tselentis, Y1
Binstock, P; Keating, M; Kontoyiannis, DP; Nannini, EC; Samonis, G1
Kyle, SD; Porter, WM1
Borrás, R; de Julián-Ortiz, JV; Domínguez, V; Gálvez, J; García-García, A; Guna, R; Muñoz, C1
Jackson, MA; Selvarangan, R; Sharma, M; Thorell, EA; Woods, GM1
Tam, WO; Tse, TF; Wong, PC; Yam, WC; Yew, WW; Yuen, KY1
Fierlbeck, G; Hoetzenecker, W; Kempf, VA; Klingel, K; Metzler, G; Schanz, S; Ulmer, A1
Alffenaar, JW; Bolhuis, MS; Kosterink, JG; Uges, DR; van Altena, R; van der Werf, TS1
Lin, YH; Liu, TC1
Borole, AJ; Chilgar, RM; D'Silva, JA; Thomas, M1
Alffenaar, JW; Bolhuis, MS; de Lange, WC; Kosterink, JG; Uges, DR; van Altena, R; van der Werf, TS; van Soolingen, D1
Alffenaar, JW; Bolhuis, MS; de Lange, WC; Greijdanus, B; Kosterink, JG; Uges, DR; van Altena, R; van der Werf, TS; van Hateren, K1
Hayashi, S; Iwamoto, T; Okada, M; Saito, H; Suzuki, K; Tomita, M; Tsuyuguchi, K; Yoshida, S1
Gui, J; Hong, CY; Li, JL; Liang, J; Wang, F1
Migliori, GB; Peloquin, CA; Sotgiu, G; Srivastava, S1
Alffenaar, JW; Bolhuis, MS; Kosterink, JG; van der Laan, T; van der Werf, TS; van Soolingen, D1
Alves, SH; Loreto, ES; Pilotto, MB; Santurio, JM; Tondolo, JS1
Dupin, N; Guillemain, R; Hamelin, A; Lortholary, O; Morand, PC; Parize, P; Veziris, N1
Altboum, Z; Bar-David, E; Glinert, I; Kobiler, D; Levy, H; Schlomovitz, J; Sittner, A; Weiss, S1
Boyanova, L; Evstatiev, I; Gergova, G; Mitov, I; Yaneva, P1
Beitz, A; Ehmer, U; Eser, S; Fekecs, L; Huber, W; Lahmer, T; Messer, M; Schmid, RM1
Bohnert, JA; Handzlik, J; Kaczor, A; Karcz, T; Kern, WV; Kieć-Kononowicz, K; Olejarz, A; Schuster, S1
Carrillo-Alascio, PL; Guirao-Arrabal, E; León-Ruíz, L; Pérez-Sola, MJ1
Achar, J; Bobokhojaev, OI; du Cros, P; Dusmatova, Z; Quinnell, S; Seddon, JA; Swaminathan, A1
Abou-Aisha, K; Akram, FE; El-Azizi, M; El-Tayeb, T1
Bouziane, F; Cambau, E; Chau, F; Crockett, F; Mougari, F; Nessar, R; Raskine, L; Sapriel, G; Veziris, N1
Olesen, JS; Wang, M; Wejse, C1
Chen, HC; Huang, CC; Huang, WC; Wu, MF1
Arthur, M; Compain, F; Dorchène, D; Dubée, V; Gaillard, JL; Herrmann, JL; Heym, B; Soroka, D1
Alves, SH; Loreto, ES; Oliveira, DC; Santurio, JM; Tondolo, JSM1
Almeida, DV; Converse, PJ; Grosset, JH; Lee, J; Li, SY; Nuermberger, EL; Omansen, TF1
Azzawi, S; Hoang, MP; Smith, GP1
Gonzales Zamora, JA; Villar Astete, A1
Fukui, M; Marumo, S; Shirata, M; Tamai, K; Yoshimoto, Y1
Arya, R; Cheon, DH; Choi, Y; Chong, YP; Choo, S; Hyun, S; Jin, SM; Jo, D; Kim, KK; Kim, S; Kim, YS; Lee, S; Lee, Y; Park, S; Park, SJ; Park, TW; Yoo, W; Yu, J1
Arai, Y; Iguchi, S; Kamada, K; Kikuchi, K; Konno, S; Shimojima, M; Uzawa, Y; Yoshida, A1
Ölmez, S; Otlu, B; Sancak, B; Şener, B1
Arslan, N; Esen, N; Özkarataş, MH; Özkütük, AA1
Ahmad Khosravi, N; Hashemi Shahraki, A; Hashemzadeh, M; Khosravi, AD; Zadegan Dezfuli, AA1
Fu, X; Gao, B; Li, S; Li, Y; Liu, X; Ma, B; Mao, Y; Pang, Y; Ren, W; Shang, Y; Sun, L; Xu, J; Zhu, P1
Faksri, K; Hinwan, Y; Kaewprasert, O; Sirichoat, A1

Reviews

1 review(s) available for clarithromycin and linezolid

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

2 trial(s) available for clarithromycin and linezolid

ArticleYear
Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients.
    The European respiratory journal, 2013, Volume: 42, Issue:6

    Topics: Acetamides; Adult; Aged; Antitubercular Agents; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clarithromycin; Drug Interactions; Drug Monitoring; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Prospective Studies; Tuberculosis, Multidrug-Resistant; Young Adult

2013
Clinical validation of the analysis of linezolid and clarithromycin in oral fluid of patients with multidrug-resistant tuberculosis.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:8

    Topics: Acetamides; Adult; Antitubercular Agents; Area Under Curve; Clarithromycin; Confidence Intervals; Drug Monitoring; Female; Humans; Linezolid; Male; Metabolic Clearance Rate; Oxazolidinones; Prospective Studies; Saliva; Tuberculosis, Multidrug-Resistant; Young Adult

2013

Other Studies

59 other study(ies) available for clarithromycin and linezolid

ArticleYear
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4

    Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen

2007
In vitro activity of aurein 1.2 alone and in combination with antibiotics against gram-positive nosocomial cocci.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4

    Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cross Infection; Drug Synergism; Drug Therapy, Combination; Gram-Positive Cocci; Microbial Sensitivity Tests

2007
Prevalence, characteristics, and molecular epidemiology of macrolide and fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae at five tertiary-care hospitals in Korea.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Anti-Bacterial Agents; Community-Acquired Infections; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Genes, Bacterial; Hospitals; Humans; Korea; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Molecular Epidemiology; Mutation; Ofloxacin; Pneumococcal Infections; Polymerase Chain Reaction; Prevalence; Reserpine; Respiratory Tract Infections; Retrospective Studies; Streptococcus pneumoniae

2007
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance

2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Site-directed mutagenesis reveals amino acid residues in the Escherichia coli RND efflux pump AcrB that confer macrolide resistance.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Macrolides; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Mutagenesis, Site-Directed; Sequence Homology, Amino Acid

2009
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Chromosome Walking; DNA-Binding Proteins; Genetic Engineering; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Point Mutation; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Staphylococcus aureus; Vancomycin; Vancomycin Resistance

2009
Bacteriostatic and bactericidal activities of tigecycline against Coxiella burnetii and comparison with those of six other antibiotics.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Chlorocebus aethiops; Coxiella burnetii; Humans; Microbial Sensitivity Tests; Minocycline; Q Fever; Tigecycline; Vero Cells

2009
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:9

    Topics: Anti-Bacterial Agents; China; Cities; Drug Resistance, Multiple, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin; Vancomycin Resistance

2009
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:9

    Topics: Antitubercular Agents; Disinfectants; Drug Resistance, Bacterial; Glutaral; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium chelonae; Mycobacterium smegmatis; o-Phthalaldehyde; Porins

2009
In vivo characterization of the peptide deformylase inhibitor LBM415 in murine infection models.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:9

    Topics: Acetamides; Amidohydrolases; Animals; Anti-Infective Agents; Female; Linezolid; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Peptides; Pneumonia; Staphylococcus aureus; Streptococcus pneumoniae; Thigh

2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Rapid assessment of antibacterial activity against Mycobacterium ulcerans by using recombinant luminescent strains.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7

    Topics: Anti-Bacterial Agents; Erythromycin; Luminescent Proteins; Microbial Sensitivity Tests; Models, Genetic; Mycobacterium ulcerans; Reserpine; Tetracycline

2010
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9

    Topics: Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chlortetracycline; Dipeptides; Doxorubicin; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Minocycline; Onium Compounds; Organophosphorus Compounds; Tetracycline

2010
Novel 3-O-carbamoyl erythromycin A derivatives (carbamolides) with activity against resistant staphylococcal and streptococcal isolates.
    Bioorganic & medicinal chemistry letters, 2013, Mar-15, Volume: 23, Issue:6

    Topics: Anti-Bacterial Agents; Binding Sites; Crystallography, X-Ray; Deinococcus; Drug Resistance, Bacterial; Erythromycin; Escherichia coli; Methylurea Compounds; Microbial Sensitivity Tests; Protein Structure, Tertiary; Pyrrolidines; Ribosome Subunits, Large, Bacterial; Staphylococcus; Streptococcus

2013
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Design, synthesis and structure-based optimization of novel isoxazole-containing benzamide derivatives as FtsZ modulators.
    European journal of medicinal chemistry, 2018, Nov-05, Volume: 159

    Topics: Anti-Bacterial Agents; Bacillus pumilus; Bacillus subtilis; Bacterial Proteins; Benzamides; Cell Survival; Cytoskeletal Proteins; Dose-Response Relationship, Drug; Drug Design; HeLa Cells; Humans; Isoxazoles; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship

2018
Design, synthesis of novel 4,5-dihydroisoxazole-containing benzamide derivatives as highly potent FtsZ inhibitors capable of killing a variety of MDR Staphylococcus aureus.
    Bioorganic & medicinal chemistry, 2020, 11-01, Volume: 28, Issue:21

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Benzamides; Binding Sites; Cell Survival; Cytoskeletal Proteins; Drug Design; Drug Resistance, Bacterial; Drug Stability; Gram-Negative Bacteria; Gram-Positive Bacteria; HeLa Cells; Humans; Isoxazoles; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Structure-Activity Relationship

2020
In vitro activities of linezolid alone and in combination with amoxicillin, clarithromycin, and metronidazole against Helicobacter pylori.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:7

    Topics: Acetamides; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Helicobacter pylori; Humans; Linezolid; Metronidazole; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Penicillins

2000
In vitro susceptibility of Coxiella burnetii to linezolid in comparison with its susceptibilities to quinolones, doxycycline, and clarithromycin.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:11

    Topics: Acetamides; Animals; Anti-Bacterial Agents; Chlorocebus aethiops; Clarithromycin; Coxiella burnetii; Doxycycline; Fluoroquinolones; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Q Fever; Vero Cells

2001
Successful treatment of refractory disseminated Mycobacterium avium complex infection with the addition of linezolid and mefloquine.
    The Journal of infection, 2002, Volume: 44, Issue:3

    Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Clarithromycin; Drug Therapy, Combination; Ethambutol; Fatal Outcome; Fluoroquinolones; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Linezolid; Male; Mefloquine; Middle Aged; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Oxazolidinones; Quinolines

2002
Mycobacterium chelonae infection successfully treated with oral clarithromycin and linezolid.
    The British journal of dermatology, 2004, Volume: 151, Issue:5

    Topics: Acetamides; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Forearm; Humans; Linezolid; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Opportunistic Infections; Oxazolidinones; Skin Diseases, Bacterial

2004
In vitro activity of linezolid, clarithromycin and moxifloxacin against clinical isolates of Mycobacterium kansasii.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 55, Issue:6

    Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Clarithromycin; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium kansasii; Oxazolidinones; Quinolines

2005
Disseminated nontuberculous mycobacterial infections in sickle cell anemia patients.
    Journal of pediatric hematology/oncology, 2006, Volume: 28, Issue:10

    Topics: Acetamides; Adolescent; Amikacin; Anemia, Sickle Cell; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Doxycycline; Drug Therapy, Combination; Female; Humans; Hydroxyurea; Linezolid; Microbial Sensitivity Tests; Mycobacterium fortuitum; Mycobacterium Infections; Oxazolidinones; Treatment Outcome

2006
Pacemaker infections due to rapidly growing mycobacteria: further experience.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2007, Volume: 11, Issue:1

    Topics: Acetamides; Aged; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Humans; Linezolid; Mycobacterium Infections; Ofloxacin; Oxazolidinones; Pacemaker, Artificial; Prosthesis-Related Infections; Surgical Wound Infection

2007
Dissemination of a localized cutaneous infection with Mycobacterium chelonae under immunosuppressive treatment.
    Archives of dermatology, 2007, Volume: 143, Issue:7

    Topics: Acetamides; Anti-Infective Agents; Clarithromycin; Diagnosis, Differential; Female; Humans; Immunocompromised Host; Linezolid; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Oxazolidinones; Skin Ulcer

2007
Clarithromycin significantly increases linezolid serum concentrations.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12

    Topics: Acetamides; Adult; Chromatography, Liquid; Clarithromycin; Clofazimine; Cycloserine; Drug Interactions; Humans; Linezolid; Male; Oxazolidinones; Tandem Mass Spectrometry; Tuberculosis, Pulmonary

2010
Mycobacterium chelonae infection involving the auricle.
    QJM : monthly journal of the Association of Physicians, 2012, Volume: 105, Issue:10

    Topics: Acetamides; Adult; Anti-Infective Agents; Clarithromycin; Ear Auricle; Humans; Linezolid; Lymph Nodes; Lymphadenitis; Male; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Neck; Oxazolidinones; Skin Diseases, Bacterial; Treatment Outcome

2012
Periprosthetic atypical mycobacterial infection in breast implants: a new kid on the block!
    Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 2013, Volume: 66, Issue:1

    Topics: Acetamides; Adult; Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Breast Implants; Clarithromycin; Female; Fluoroquinolones; Gatifloxacin; Humans; Linezolid; Mammaplasty; Mycobacterium chelonae; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Oxazolidinones; Reoperation

2013
Further isolation of Mycobacterium abscessus subsp. abscessus and subsp. bolletii in different regions of Japan and susceptibility of these isolates to antimicrobial agents.
    International journal of antimicrobial agents, 2013, Volume: 42, Issue:3

    Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Chaperonin 60; Clarithromycin; DNA-Directed RNA Polymerases; DNA, Intergenic; Drug Resistance, Bacterial; Female; Genotype; Humans; Japan; Linezolid; Male; Methyltransferases; Microbial Sensitivity Tests; Middle Aged; Mycobacterium; Mycobacterium Infections; Oxazolidinones; RNA, Ribosomal, 23S; Sequence Analysis, DNA

2013
[Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
    Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2013, Volume: 36, Issue:8

    Topics: Acetamides; Amikacin; Anti-Bacterial Agents; Cefoxitin; Clarithromycin; Culture Media; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Oxazolidinones; Sensitivity and Specificity; Tobramycin

2013
Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment?
    The European respiratory journal, 2013, Volume: 42, Issue:6

    Topics: Acetamides; Antitubercular Agents; Clarithromycin; Female; Humans; Linezolid; Male; Oxazolidinones; Tuberculosis, Multidrug-Resistant

2013
In vitro synergy between linezolid and clarithromycin against Mycobacterium tuberculosis.
    The European respiratory journal, 2014, Volume: 44, Issue:3

    Topics: Acetamides; Anti-Bacterial Agents; Biological Specimen Banks; Clarithromycin; Drug Resistance, Bacterial; Drug Synergism; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis, Multidrug-Resistant

2014
New insights into the in vitro susceptibility of Pythium insidiosum.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:12

    Topics: Acetamides; Anti-Bacterial Agents; Antifungal Agents; Azithromycin; Clarithromycin; Doxycycline; Linezolid; Microbial Sensitivity Tests; Minocycline; Mupirocin; Oxazolidinones; Pythium; Tigecycline

2014
Induction therapy with linezolid/clarithromycin combination for Mycobacterium chelonae skin infections in immunocompromised hosts.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2016, Volume: 30, Issue:1

    Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Combinations; Female; France; Humans; Immunocompromised Host; Linezolid; Male; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Retrospective Studies; Skin Diseases, Bacterial; Treatment Outcome

2016
Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12

    Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Bacteremia; Ciprofloxacin; Clarithromycin; Disease Models, Animal; Doxycycline; Drug Combinations; Drug Synergism; Humans; Imipenem; Linezolid; Male; Microbial Sensitivity Tests; Rabbits; Respiratory Tract Infections; Rifampin; Spores, Bacterial; Survival Analysis; Vancomycin

2015
Linezolid susceptibility in Helicobacter pylori, including strains with multidrug resistance.
    International journal of antimicrobial agents, 2015, Volume: 46, Issue:6

    Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Linezolid; Metronidazole; Microbial Sensitivity Tests; Tetracycline

2015
Pseudallescheria boydii with Aspergillus fumigatus and Aspergillus terreus in a Critically Ill Hematopoietic Stem Cell Recipient with ARDS.
    Mycopathologia, 2016, Volume: 181, Issue:3-4

    Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; beta-Glucans; Clarithromycin; Coinfection; Critical Illness; Extracorporeal Membrane Oxygenation; Galactose; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Linezolid; Male; Mannans; Meropenem; Pneumonia; Pseudallescheria; Severe Acute Respiratory Syndrome; Thienamycins; Transplant Recipients; Voriconazole

2016
Novel Piperazine Arylideneimidazolones Inhibit the AcrAB-TolC Pump in Escherichia coli and Simultaneously Act as Fluorescent Membrane Probes in a Combined Real-Time Influx and Efflux Assay.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Biological Assay; Biological Transport; Cell Membrane; Cephalosporins; Clarithromycin; Drug Synergism; Escherichia coli; Escherichia coli Proteins; Fluorescent Dyes; Gene Expression; Imidazoles; Indicators and Reagents; Kinetics; Levofloxacin; Linezolid; Membrane Proteins; Membrane Transport Proteins; Microbial Sensitivity Tests; Oxacillin; Piperazines; Protein Kinases; Repressor Proteins; Rifampin

2016
Clarithromycin plus linezolid as a sequential therapy for implantable-cardioverter-defibrillator infection caused by coagulase-negative staphylococci.
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2016, Volume: 29, Issue:2

    Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Defibrillators, Implantable; Echocardiography; Humans; Linezolid; Male; Myocardial Ischemia; Prosthesis-Related Infections; Staphylococcal Infections; Treatment Outcome

2016
Treating children for drug-resistant tuberculosis in Tajikistan with Group 5 medications.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2016, Volume: 20, Issue:4

    Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; Child; Child, Preschool; Clarithromycin; Clofazimine; Drug Combinations; Extensively Drug-Resistant Tuberculosis; Female; Follow-Up Studies; Humans; Linezolid; Male; Retrospective Studies; Sputum; Tajikistan; Treatment Outcome

2016
A combination of silver nanoparticles and visible blue light enhances the antibacterial efficacy of ineffective antibiotics against methicillin-resistant Staphylococcus aureus (MRSA).
    Annals of clinical microbiology and antimicrobials, 2016, Aug-17, Volume: 15, Issue:1

    Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Combined Modality Therapy; Drug Combinations; Drug Synergism; Light; Linezolid; Metal Nanoparticles; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phototherapy; Silver; Vancomycin

2016
Selection of Resistance to Clarithromycin in Mycobacterium abscessus Subspecies.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Imipenem; Linezolid; Microbial Sensitivity Tests; Minocycline; Mutation; Mycobacterium; Tigecycline

2017
Mycobacterium chelonae hand infection after steroid injection in a patient with rheumatoid arthritis receiving long-term linezolid therapy.
    BMJ case reports, 2017, Jan-30, Volume: 2017

    Topics: Adrenal Cortex Hormones; Aged; Amputation, Surgical; Anti-Bacterial Agents; Arthritis, Rheumatoid; Clarithromycin; Drug Therapy, Combination; Fluoroquinolones; Hand; Humans; Injections; Injections, Intra-Articular; Linezolid; Male; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Tenosynovitis

2017
In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2018, Volume: 51, Issue:5

    Topics: Aminoglycosides; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Cycloserine; Drug Synergism; Fluoroquinolones; Gentamicins; Humans; Linezolid; Microbial Sensitivity Tests; Microbial Viability; Moxifloxacin; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Sputum; Streptomycin

2018
In vitro activity of tedizolid against the Mycobacterium abscessus complex.
    Diagnostic microbiology and infectious disease, 2018, Volume: 90, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Oxazolidinones; Tetrazoles; Tigecycline

2018
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bridged Bicyclo Compounds, Heterocyclic; Clarithromycin; Diterpenes; Humans; Josamycin; Linezolid; Macrolides; Oomycetes; Oxazolidinones; Phosphorylcholine; Pleuromutilins; Polycyclic Compounds; Pythiosis; Pythium

2018
Oxazolidinones Can Replace Clarithromycin in Combination with Rifampin in a Mouse Model of Buruli Ulcer.
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Disease Models, Animal; Female; Linezolid; Mice; Mice, Inbred BALB C; Mycobacterium ulcerans; Oxazolidinones; Rifampin; Tetrazoles

2019
New onset erythematous nodules in an elderly woman.
    Dermatology online journal, 2018, Aug-15, Volume: 24, Issue:8

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Erythema; Fatigue; Female; Humans; Linezolid; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Tuberculosis, Cutaneous; Weight Loss

2018
    Acta clinica Belgica, 2020, Volume: 75, Issue:6

    Topics: Abscess; Anti-Bacterial Agents; Clarithromycin; Debridement; Female; Finger Phalanges; Humans; Imipenem; Linezolid; Magnetic Resonance Imaging; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Osteomyelitis; Tigecycline

2020
In vitro efficacy of combinations of eight antimicrobial agents against Mycobacteroides abscessus complex.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 97

    Topics: Actinomycetales Infections; Amikacin; Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Doxycycline; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacteriaceae; Sequence Analysis, DNA

2020
Proline Hinged Amphipathic α-Helical Peptide Sensitizes Gram-Negative Bacteria to Various Gram-Positive Antibiotics.
    Journal of medicinal chemistry, 2020, 12-10, Volume: 63, Issue:23

    Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cell Membrane; Clarithromycin; Escherichia coli; Female; Hemolysis; Humans; Hydrophobic and Hydrophilic Interactions; Linezolid; Lipid A; Membrane Fluidity; Mice, Inbred ICR; Microbial Sensitivity Tests; Proline; Protein Binding; Protein Conformation, alpha-Helical; Rifampin

2020
Nationwide surveillance of antimicrobial susceptibility of 509 rapidly growing mycobacteria strains isolated from clinical specimens in Japan.
    Scientific reports, 2021, 06-09, Volume: 11, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Humans; Japan; Linezolid; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria

2021
[The Importance of Gram-stained Smears in the Diagnosis of Nocardia Infections].
    Mikrobiyoloji bulteni, 2023, Volume: 57, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cefotaxime; Ceftriaxone; Ciprofloxacin; Clarithromycin; Humans; Imipenem; Linezolid; Nocardia; Nocardia Infections; RNA, Ribosomal, 16S; Trimethoprim, Sulfamethoxazole Drug Combination

2023
[Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria].
    Mikrobiyoloji bulteni, 2023, Volume: 57, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Doxycycline; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Tobramycin

2023
Frequency of mutations in erm(39) related to clarithromycin resistance and in rrl related to linezolid resistance in clinical isolates of Mycobacterium fortuitum in Iran.
    Acta microbiologica et immunologica Hungarica, 2023, Jun-16, Volume: 70, Issue:2

    Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Iran; Linezolid; Microbial Sensitivity Tests; Mutation; Mycobacterium fortuitum; Nontuberculous Mycobacteria

2023
Rapid Mycobacterium abscessus antimicrobial susceptibility testing based on antibiotic treatment response mapping via Raman Microspectroscopy.
    Annals of clinical microbiology and antimicrobials, 2023, Oct-30, Volume: 22, Issue:1

    Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria

2023
Phenotypic drug-susceptibility profiles and genetic analysis based on whole-genome sequencing of Mycobacterium avium complex isolates in Thailand.
    PloS one, 2023, Volume: 18, Issue:11

    Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Phylogeny; Thailand

2023